208 related articles for article (PubMed ID: 16498458)
1. Targeting NF-kappaB in hematologic malignancies.
Braun T; Carvalho G; Fabre C; Grosjean J; Fenaux P; Kroemer G
Cell Death Differ; 2006 May; 13(5):748-58. PubMed ID: 16498458
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies.
Panwalkar A; Verstovsek S; Giles F
Cancer; 2004 Apr; 100(8):1578-89. PubMed ID: 15073843
[TBL] [Abstract][Full Text] [Related]
4. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
5. NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.
Breccia M; Alimena G
Expert Opin Ther Targets; 2010 Nov; 14(11):1157-76. PubMed ID: 20858024
[TBL] [Abstract][Full Text] [Related]
6. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB in cancer--a friend turned foe.
Ravi R; Bedi A
Drug Resist Updat; 2004 Feb; 7(1):53-67. PubMed ID: 15072771
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.
Lopez-Guerra M; Colomer D
Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
Van Waes C
Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
[TBL] [Abstract][Full Text] [Related]
10. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
11. The role of ubiquitin in NF-kappaB regulatory pathways.
Skaug B; Jiang X; Chen ZJ
Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
[TBL] [Abstract][Full Text] [Related]
12. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
13. Deregulated NF-kappaB activity in haematological malignancies.
Keutgens A; Robert I; Viatour P; Chariot A
Biochem Pharmacol; 2006 Oct; 72(9):1069-80. PubMed ID: 16854381
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
Oncogene; 2007 Jun; 26(28):4071-83. PubMed ID: 17213804
[TBL] [Abstract][Full Text] [Related]
15. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.
Fuchs O
Curr Mol Pharmacol; 2010 Nov; 3(3):98-122. PubMed ID: 20594187
[TBL] [Abstract][Full Text] [Related]
17. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
Schmid JA; Birbach A
Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB activation: from bench to bedside.
Sethi G; Sung B; Aggarwal BB
Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
[TBL] [Abstract][Full Text] [Related]
19. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]